Baclofen in the Treatment of Detrusor-sphincter Dyssynergia in Spinal Cord Injury Patients
- 1 July 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 124 (1) , 82-84
- https://doi.org/10.1016/s0022-5347(17)55307-0
Abstract
The pharmacodynamics of baclofen on the bladder and urethral sphincters in male acute and chronic spinal cord injury patients were evaluated. A total of 100 supine and sitting urodynamic profiles was done in 25 patients. Baclofen decreased external urethral sphincter resistance by depressing pudendal-to-pudendal nerve reflex through spinal cord presynaptic hyperpolarization. This new centrally acting antispastic drug produced a significant reduction of residual urine in 73% of the cases within an average of 4.98 wk. Baclofen is a new alternative in the medical treatment of postural nonelectrically induced detrusor striated sphincter dyssynergia in spinal cord injury patients. Indications for external sphincterotomy are discussed.This publication has 8 references indexed in Scilit:
- Effects of Bethanechol Chloride on the External Urethral Sphincter in Spinal Cord Injury PatientsJournal of Urology, 1978
- Effect of baclofen and dantrolene on bladder stimulator-induced detrusor-sphincter dyssynergia in dogsUrology, 1978
- Effect of Dantrolene Sodium on the Spastic External Urethral Sphincter Recorded by SphincterometryJournal of Urology, 1978
- Antagonism between Lioresal and substance P in rat spinal cordBrain Research, 1975
- Lioresal in the Treatment of Neurogenic Bladder DysfunctionUrologia Internationalis, 1975
- Central effects of β-(p-chlorophenyl)-γ-aminobutyric acidBrain Research, 1974
- The action of a GABA derivative in human spasticityJournal of the Neurological Sciences, 1971
- INTRATHECAL PHENOL TO RELIEVE SPASTICITY IN PARAPLEGIAThe Lancet, 1959